| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.0M | +8.9% |
| Cost of Revenue | $6.0M | +8.7% |
| Gross Profit | $9.0M | +9.0% |
| R&D Expense | $100K | +0.0% |
| SG&A Expense | $17.9M | -20.5% |
| Operating Income | -$11.2M | +35.4% |
| Pre-tax Income | -$11.1M | +18.0% |
| Net Income | -$11.1M | +18.0% |
| EPS (Basic) | -$2.22 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.3M | +281.0% |
| Accounts Receivable | $430K | +112.9% |
| Current Assets | $7.5M | +203.7% |
| Total Assets | $15.3M | +42.4% |
| Current Liabilities | $5.0M | -31.7% |
| Long-term Debt | $1.2M | +0.0% |
| Total Liabilities | $7.3M | -29.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.7M | -6.2% |
| Capital Expenditures | $568K | -29.3% |
| Investing Cash Flow | -$568K | +33.4% |
| Financing Cash Flow | $17.9M | +63.7% |
| Free Cash Flow | -$13.3M | -4.0% |
| +80.1% |
| EPS (Diluted) | -$2.22 | +80.1% |
| Stockholders' Equity |
| $8.0M |
| +1835.3% |